Enteral Nutrition Market by Protein Composition (Standard Protein Diet, High Protein Supplement, Protein for Diabetes Care Patient and Others), Form (Powder and Liquid), Age Group (Adults, and Pediatric), and Distribution Channel (Hospital Sales, Retail, and Online): Global Opportunity Analysis and Industry Forecast, 2020–2027

April 2021 | 343 pages | ID: EECE7AC5D12EN
Allied Market Research

Abstracts

The global drug-eluting stents market was valued at $6,762 million in 2018, and is projected to reach $12,294 million by 2027, registering a CAGR of 7.1% from 2020 to 2027.

Enteral nutrition is prescribed to patients, who are unable to consume sufficient nutrients orally but whose gastrointestinal function is a satisfactory condition for digestion and absorption. This process is deployed when a patient is unable to eat due to some illness, has swallowing difficulties, or surgery that may interfere with the normal eating process. The enteral nutrients are administered directly into the stomach, duodenum, or jejunum of a patient via enteral pumps and enteral feeding tubes. Enteral nutrients are prescribed to patients suffering from chronic illness such as malnutrition, gastrointestinal disorder, cancer, and others. Generally, enteral feeding is deployed in an operation theatre (OT), intensive care unit (ICU), and critical care unit (CCU), and even at home for severely ill patients.

Rise in prevalence of chronic disorders such as cancer and neurological disorders is the major factor that contributes toward the growth of the enteral nutrition market. Other factors that fuel the market growth include increase in geriatric population, and surge in malnutrition cases. Over the years, enteral nutrition is gaining acceptance, owing to the enhancement in techniques, configurations, and ingredients. However, poor demand and lack of awareness of enteral nutrition in underdeveloped countries hamper the market growth. Conversely, development of new technologically advanced products and high market potential in untapped emerging economies are expected to provide lucrative opportunities for the growth of the market.

The enteral nutrition market is segmented into protein composition, form, age group, distribution channel, and region. By protein composition, the market is divided into standard protein diet, high protein supplement, protein for diabetes care patient, and others. By form, the market is bifurcated into powder and liquid. By age group, the market is bifurcated into adults (above 18) and pediatric (below 18). By distribution channel, the market is classified into hospital sales, retail, and online. By region, the enteral nutrition market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

• The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2018 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
• A comprehensive analysis of four regions is provided to determine the existing opportunities.
• Profiles and growth strategies of key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Protein Composition

• Standard Protein Diet
• High Protein Supplement
• Protein for Diabetes Care Patient
• Others

By Form

• Powder
• Liquid

By Age Group

• Adults (Above 18)
• Pediatric (Below 18)

By Distribution Channel

• Hospital Sales
• Retail
• Online

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

• Abbott Laboratories
• B. Braun Melsungen AG
• Danone S.A.
• Fresenius Kabi AG
• Global Health Products, Inc.
• Hormel Foods Corporation
• Meiji Holdings Co., Ltd.
• Nestl? S.A.
• Reckitt Benckinser Group PLC,
• Victus, Inc.

Contents

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
  1.3.1.List of key players profiled in the report
1.4.Research methodology
  1.4.1.Secondary research
  1.4.2.Primary research
  1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings
  3.2.1.Top investment pockets
  3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2018
3.5.Market dynamics
  3.5.1.Drivers
    3.5.1.1.Growth in incidence of chronic diseases
    3.5.1.2.Rapid growth in geriatric population
    3.5.1.3.Rise in number of malnutrition cases
    3.5.1.4.High adoption of enteral nutrition over parenteral nutrition
  3.5.2.Restraint
    3.5.2.1.Poor demand in underdeveloped countries
  3.5.3.Opportunities
    3.5.3.1.Growth opportunities in emerging markets
  3.5.4.Impact analysis
3.6.List of key brands (up to 5)
  3.6.1.Adult oral (sip feed) enteral nutrition
  3.6.2.Adult tube feeding enteral nutrition
  3.6.3.Pediatric oral (sip feed) enteral nutrition
  3.6.4.Pediatric tube feeding enteral nutrition
  3.6.5.Pediatric tolerance infant formula
  3.6.6.Pediatric extensively hydrolyzed and amino acid infant formula
3.7.Sales data for key brands
3.8.Covid-19 Impact analysis on enteral nutrition market

CHAPTER 4:ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITIONS

4.1.Overview
  4.1.1.Market size and forecast
4.2.Standard protein diet
  4.2.1.Key market trends, growth factors, and opportunities
  4.2.2.Market size and forecast, by region
  4.2.3.Market analysis, by country
  4.2.4.List on key brands (up to 10)
4.3.High protein supplement
  4.3.1.Key market trends, growth factors, and opportunities
  4.3.2.Market size and forecast, by region
  4.3.3.Market analysis, by country
  4.3.4.List on key brands (up to 10)
4.4.Protein for diabetes care patient
  4.4.1.Key market trends, growth factors, and opportunities
  4.4.2.Market size and forecast, by region
  4.4.3.Market analysis, by country
  4.4.4.List on key brands (up to 10)
4.5.Others
  4.5.1.Key market trends, growth factors, and opportunities
  4.5.2.Market size and forecast, by region
  4.5.3.Market analysis, by country
  4.5.4.List on key brands (up to 10)

CHAPTER 5:ENTERAL NUTRITION MARKET, BY FORM

5.1.Overview
  5.1.1.Market size and forecast
5.2.Powder
  5.2.1.Market size and forecast, by region
  5.2.2.Market analysis, by country
5.3.Liquid
  5.3.1.Market size and forecast, by region
  5.3.2.Market analysis, by country

CHAPTER 6:ENTERAL NUTRITION MARKET, BY AGE GROUP

6.1.Overview
  6.1.1.Market size and forecast by age group
6.2.Adults (above 18)
  6.2.1.Market size and forecast, by region
  6.2.2.Market analysis, by country
  6.2.3.List on key brands (up to 10)
6.3.Pediatric (below 18)
  6.3.1.Market size and forecast, by region
  6.3.2.Market analysis, by country
  6.3.3.List on key brands (up to 10)

CHAPTER 7:ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL

7.1.Overview
  7.1.1.Market size and forecast
7.2.Hospital sales
  7.2.1.Market size and forecast, by region
  7.2.2.Market analysis, by country
7.3.Retail
  7.3.1.Market size and forecast, by region
  7.3.2.Market analysis, by country
7.4.Online
  7.4.1.Market size and forecast, by region
  7.4.2.Market analysis, by country

CHAPTER 8:ENTERAL NUTRITION MARKET, BY REGION

8.1.Overview
  8.1.1.Market size and forecast
8.2.North America
  8.2.1.Key market trends, growth factors, and opportunities
  8.2.2.Market size and forecast, by country
    8.2.2.1.U.S.
      8.2.2.1.1.Market size and forecast, by protein composition
      8.2.2.1.2.Market size and forecast, by form
      8.2.2.1.3.Market size and forecast, by age group
      8.2.2.1.4.Market size and forecast, by distribution channel
    8.2.2.2.Canada
      8.2.2.2.1.Market size and forecast, by protein composition
      8.2.2.2.2.Market size and forecast, by form
      8.2.2.2.3.Market size and forecast, by age group
      8.2.2.2.4.Market size and forecast, by distribution channel
    8.2.2.3.Mexico
      8.2.2.3.1.Market size and forecast, by protein composition
      8.2.2.3.2.Market size and forecast, by form
      8.2.2.3.3.Market size and forecast, by age group
      8.2.2.3.4.Market size and forecast, by distribution channel
  8.2.3.North America market size and forecast, by protein composition
  8.2.4.North America market size and forecast, by form
  8.2.5.North America market size and forecast, by age group
  8.2.6.North America market size and forecast, by distribution channel
8.3.Europe
  8.3.1.Key market trends, growth factors, and opportunities
  8.3.2.Market size and forecast, by country
    8.3.2.1.Germany
      8.3.2.1.1.Market size and forecast, by protein composition
      8.3.2.1.2.Market size and forecast, by form
      8.3.2.1.3.Market size and forecast, by age group
      8.3.2.1.4.Market size and forecast, by distribution channel
    8.3.2.2.France
      8.3.2.2.1.Market size and forecast, by protein composition
      8.3.2.2.2.Market size and forecast, by form
      8.3.2.2.3.Market size and forecast, by age group
      8.3.2.2.4.Market size and forecast, by distribution channel
    8.3.2.3.UK
      8.3.2.3.1.Market size and forecast, by protein composition
      8.3.2.3.2.Market size and forecast, by form
      8.3.2.3.3.Market size and forecast, by age group
      8.3.2.3.4.Market size and forecast, by distribution channel
    8.3.2.4.Italy
      8.3.2.4.1.Market size and forecast, by protein composition
      8.3.2.4.2.Market size and forecast, by form
      8.3.2.4.3.Market size and forecast, by age group
      8.3.2.4.4.Market size and forecast, by distribution channel
    8.3.2.5.Spain
      8.3.2.5.1.Market size and forecast, by protein composition
      8.3.2.5.2.Market size and forecast, by form
      8.3.2.5.3.Market size and forecast, by age group
      8.3.2.5.4.Market size and forecast, by distribution channel
    8.3.2.6.Rest of Europe
      8.3.2.6.1.Market size and forecast, by protein composition
      8.3.2.6.2.Market size and forecast, by form
      8.3.2.6.3.Market size and forecast, by age group
      8.3.2.6.4.Market size and forecast, by distribution channel
  8.3.3.Europe market size and forecast, by protein composition
  8.3.4.Europe market size and forecast, by form
  8.3.5.Europe market size and forecast, by age group
  8.3.6.Europe market size and forecast, by distribution channel
8.4.Asia-Pacific
  8.4.1.Key market trends, growth factors, and opportunities
  8.4.2.Market size and forecast, by country
    8.4.2.1.Japan
      8.4.2.1.1.Market size and forecast, by protein composition
      8.4.2.1.2.Market size and forecast, by form
      8.4.2.1.3.Market size and forecast, by age group
      8.4.2.1.4.Market size and forecast, by distribution channel
    8.4.2.2.China
      8.4.2.2.1.Market size and forecast, by protein composition
      8.4.2.2.2.Market size and forecast, by form
      8.4.2.2.3.Market size and forecast, by age group
      8.4.2.2.4.Market size and forecast, by distribution channel
    8.4.2.3.Australia
      8.4.2.3.1.Market size and forecast, by protein composition
      8.4.2.3.2.Market size and forecast, by form
      8.4.2.3.3.Market size and forecast, by age group
      8.4.2.3.4.Market size and forecast, by distribution channel
    8.4.2.4.India
      8.4.2.4.1.Market size and forecast, by protein composition
      8.4.2.4.2.Market size and forecast, by form
      8.4.2.4.3.Market size and forecast, by age group
      8.4.2.4.4.Market size and forecast, by distribution channel
    8.4.2.5.South Korea
      8.4.2.5.1.Market size and forecast, by protein composition
      8.4.2.5.2.Market size and forecast, by form
      8.4.2.5.3.Market size and forecast, by age group
      8.4.2.5.4.Market size and forecast, by distribution channel
    8.4.2.6.Rest of Asia-Pacific
      8.4.2.6.1.Market size and forecast, by protein composition
      8.4.2.6.2.Market size and forecast, by form
      8.4.2.6.3.Market size and forecast, by age group
      8.4.2.6.4.Market size and forecast, by distribution channel
  8.4.3.Asia-Pacific market size and forecast, by protein composition
  8.4.4.Asia-Pacific market size and forecast, by form
  8.4.5.Asia-Pacific market size and forecast, by age group
  8.4.6.Asia-Pacific market size and forecast, by distribution channel
8.5.LAMEA
  8.5.1.Key market trends, growth factors, and opportunities
  8.5.2.Market size and forecast, by country
    8.5.2.1.Brazil
      8.5.2.1.1.Market size and forecast, by protein composition
      8.5.2.1.2.Market size and forecast, by form
      8.5.2.1.3.Market size and forecast, by age group
      8.5.2.1.4.Market size and forecast, by distribution channel
    8.5.2.2.Saudi Arabia
      8.5.2.2.1.Market size and forecast, by protein composition
      8.5.2.2.2.Market size and forecast, by form
      8.5.2.2.3.Market size and forecast, by age group
      8.5.2.2.4.Market size and forecast, by distribution channel
    8.5.2.3.South Africa
      8.5.2.3.1.Market size and forecast, by protein composition
      8.5.2.3.2.Market size and forecast, by form
      8.5.2.3.3.Market size and forecast, by age group
      8.5.2.3.4.Market size and forecast, by distribution channel
    8.5.2.4.Rest of LAMEA
      8.5.2.4.1.Market size and forecast, by protein composition
      8.5.2.4.2.Market size and forecast, by form
      8.5.2.4.3.Market size and forecast, by age group
      8.5.2.4.4.Market size and forecast, by distribution channel
  8.5.3.LAMEA market size and forecast, by protein composition
  8.5.4.LAMEA market size and forecast, by form
  8.5.5.LAMEA market size and forecast, by age group
  8.5.6.LAMEA market size and forecast, by distribution channel

CHAPTER 9:COMPANY PROFILES

9.1.ABBOTT LABORATORIES
  9.1.1.Company overview
  9.1.2.Company snapshot
  9.1.3.Operating business segments
  9.1.4.Product portfolio
  9.1.5.Business performance
  9.1.6.Key strategic moves and developments
9.2.B. BRAUN MELSUNGEN AG
  9.2.1.Company overview
  9.2.2.Company snapshot
  9.2.3.Operating business segments
  9.2.4.Product portfolio
  9.2.5.Business performance
9.3.DANONE S.A.
  9.3.1.Company overview
  9.3.2.Company snapshot
  9.3.3.Operating business segments
  9.3.4.Product portfolio
  9.3.5.Business performance
9.4.FRESENIUS KABI AG
  9.4.1.Company overview
  9.4.2.Company snapshot
  9.4.3.Operating business segments
  9.4.4.Product portfolio
  9.4.5.Business performance
9.5.GLOBAL HEALTH PRODUCTS, INC.
  9.5.1.Company overview
  9.5.2.Company snapshot
  9.5.3.Operating business segments
  9.5.4.Product portfolio
9.6.HORMEL FOODS CORPORATION
  9.6.1.Company overview
  9.6.2.Company snapshot
  9.6.3.Operating business segments
  9.6.4.Product portfolio
  9.6.5.Business performance
9.7.MEIJI HOLDINGS CO., LTD.
  9.7.1.Company overview
  9.7.2.Company snapshot
  9.7.3.Operating business segments
  9.7.4.Product portfolio
  9.7.5.Business performance
9.8.NESTLE S.A
  9.8.1.Company overview
  9.8.2.Company snapshot
  9.8.3.Operating business segments
  9.8.4.Product portfolio
  9.8.5.Business performance
  9.8.6.Key strategic moves and developments
9.9.RECKITT BENCKISER GROUP PLC.
  9.9.1.Company overview
  9.9.2.Company snapshot
  9.9.3.Operating business segments
  9.9.4.Product portfolio
  9.9.5.Business performance
  9.9.6.Key strategic moves and developments
9.10.VICTUS, INC.
  9.10.1.Company overview
  9.10.2.Company snapshot
  9.10.3.Operating business segments
  9.10.4.Product portfolio

List Of Tables

LIST OF TABLES

TABLE 01.GLOBAL ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 02.GLOBAL ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 03.ENTERAL NUTRITION MARKET FOR STANDARD PROTEIN DIET, BY REGION, 2018–2027 ($MILLION)
TABLE 04.ENTERAL NUTRITION MARKET FOR STANDARD PROTEIN DIET, BY REGION, 2018–2027 (TONS)
TABLE 05.ENTERAL NUTRITION MARKET FOR HIGH PROTEIN SUPPLEMENT, BY REGION, 2018–2027 ($MILLION)
TABLE 06.ENTERAL NUTRITION MARKET FOR HIGH PROTEIN SUPPLEMENT, BY REGION, 2018–2027 (TONS)
TABLE 07.ENTERAL NUTRITION MARKET FOR PROTEIN FOR DIABETES CARE PATIENT, BY REGION, 2018–2027 ($MILLION)
TABLE 08.ENTERAL NUTRITION MARKET FOR PROTEIN FOR DIABETES CARE PATIENT, BY REGION, 2018–2027 (TONS)
TABLE 09.ENTERAL NUTRITION MARKET FOR OTHERS, BY REGION, 2018–2027 ($MILLION)
TABLE 10.ENTERAL NUTRITION MARKET FOR OTHERS, BY REGION, 2018–2027 (TONS)
TABLE 11.GLOBAL ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 12.GLOBAL ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 13.ENTERAL NUTRITION MARKET FOR POWDER, BY REGION, 2018–2027 ($MILLION)
TABLE 14.ENTERAL NUTRITION MARKET FOR POWDER, BY REGION, 2018–2027 (TONS)
TABLE 15.ENTERAL NUTRITION MARKET FOR LIQUID, BY REGION, 2018–2027 ($MILLION)
TABLE 16.ENTERAL NUTRITION MARKET FOR LIQUID, BY REGION, 2018–2027 (TONS)
TABLE 17.GLOBAL ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 18.GLOBAL ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 19.ENTERAL NUTRITION MARKET FOR ADULTS, BY REGION, 2018–2027 ($MILLION)
TABLE 20.ENTERAL NUTRITION MARKET FOR ADULTS, BY REGION, 2018–2027 (TONS)
TABLE 21.ENTERAL NUTRITION MARKET FOR PEDIATRIC, BY REGION, 2018–2027 ($MILLION)
TABLE 22.ENTERAL NUTRITION MARKET FOR PEDIATRIC, BY REGION, 2018–2027 (TONS)
TABLE 23.GLOBAL ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 24.GLOBAL ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 25.ENTERAL NUTRITION MARKET FOR HOSPITAL SALES, BY REGION, 2018–2027 ($MILLION)
TABLE 26.ENTERAL NUTRITION MARKET FOR HOSPITAL SALES, BY REGION, 2018–2027 (TONS)
TABLE 27.ENTERAL NUTRITION MARKET FOR RETAIL, BY REGION, 2018–2027 ($MILLION)
TABLE 28.ENTERAL NUTRITION MARKET FOR RETAIL, BY REGION, 2018–2027 (TONS)
TABLE 29.ENTERAL NUTRITION MARKET FOR ONLINE, BY REGION, 2018–2027 ($MILLION)
TABLE 30.ENTERAL NUTRITION MARKET FOR ONLINE, BY REGION, 2018–2027 (TONS)
TABLE 31.ENTERAL NUTRITION MARKET, BY REGION, 2018–2027 ($MILLION)
TABLE 32.ENTERAL NUTRITION MARKET, BY REGION, 2018–2027 (TONS)
TABLE 33.NORTH AMERICA ENTERAL NUTRITION MARKET, BY COUNTRY, 2018–2027 ($MILLION)
TABLE 34.NORTH AMERICA ENTERAL NUTRITION MARKET, BY COUNTRY, 2018–2027 (TONS)
TABLE 35.U.S. ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 36.U.S. ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 37.U.S. ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 38.U.S. ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 39.U.S. ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 40.U.S. ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 41.U.S. ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 42.U.S. ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 43.CANADA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 44.CANADA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 45.CANADA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 46.CANADA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 47.CANADA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 48.CANADA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 49.CANADA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 50.CANADA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 51.MEXICO ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 52.MEXICO ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 53.MEXICO ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 54.MEXICO ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 55.MEXICO ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 56.MEXICO ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 57.MEXICO ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 58.MEXICO ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 59.NORTH AMERICA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 60.NORTH AMERICA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 61.NORTH AMERICA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 62.NORTH AMERICA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 63.NORTH AMERICA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 64.NORTH AMERICA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 65.NORTH AMERICA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 66.NORTH AMERICA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 67.EUROPE ENTERAL NUTRITION MARKET, BY COUNTRY, 2018–2027 ($MILLION)
TABLE 68.EUROPE ENTERAL NUTRITION MARKET, BY COUNTRY, 2018–2027 (TONS)
TABLE 69.GERMANY ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 70.GERMANY ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 71.GERMANY ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 72.GERMANY ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 73.GERMANY ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 74.GERMANY ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 75.GERMANY ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 76.GERMANY ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 77.FRANCE ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 78.FRANCE ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 79.FRANCE ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 80.FRANCE ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 81.FRANCE ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 82.FRANCE ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 83.FRANCE ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 84.FRANCE ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 85.UK ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 86.UK ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 87.UK ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 88.UK ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 89.UK ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 90.UK ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 91.UK ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 92.UK ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 93.ITALY ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 94.ITALY ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 95.ITALY ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 96.ITALY ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 97.ITALY ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 98.ITALY ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 99.ITALY ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 100.ITALY ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 101.SPAIN ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 102.SPAIN ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 103.SPAIN ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 104.SPAIN ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 105.SPAIN ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 106.SPAIN ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 107.SPAIN ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 108.SPAIN ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 109.REST OF EUROPE ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 110.REST OF EUROPE ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 111.REST OF EUROPE ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 112.REST OF EUROPE ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 113.REST OF EUROPE ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 114.REST OF EUROPE ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 115.REST OF EUROPE ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 116.REST OF EUROPE ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 117.EUROPE ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 118.EUROPE ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 119.EUROPE ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 120.EUROPE ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 121.EUROPE ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 122.EUROPE ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 123.EUROPE ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 124.EUROPE ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 125.ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY COUNTRY, 2018–2027 ($MILLION)
TABLE 126.ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY COUNTRY, 2018–2027 (TONS)
TABLE 127.JAPAN ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 128.JAPAN ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 129.JAPAN ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 130.JAPAN ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 131.JAPAN ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 132.JAPAN ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 133.JAPAN ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 134.JAPAN ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 135.CHINA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 136.CHINA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 137.CHINA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 138.CHINA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 139.CHINA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 140.CHINA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 141.CHINA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 142.CHINA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 143.AUSTRALIA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 144.AUSTRALIA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 145.AUSTRALIA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 146.AUSTRALIA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 147.AUSTRALIA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 148.AUSTRALIA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 149.AUSTRALIA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 150.AUSTRALIA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 151.INDIA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 152.INDIA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 153.INDIA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 154.INDIA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 155.INDIA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 156.INDIA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 157.INDIA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 158.INDIA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 159.SOUTH KOREA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 160.SOUTH KOREA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 161.SOUTH KOREA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 162.SOUTH KOREA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 163.SOUTH KOREA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 164.SOUTH KOREA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 165.SOUTH KOREA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 166.SOUTH KOREA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 167.REST OF ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 168.REST OF ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 169.REST OF ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 170.REST OF ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 171.REST OF ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 172.REST OF ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 173.REST OF ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 174.REST OF ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 175.ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 176.ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 177.ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 178.ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 179.ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 180.ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 181.ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 182.ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 183.LAMEA ENTERAL NUTRITION MARKET, BY COUNTRY, 2018–2027 ($MILLION)
TABLE 184.LAMEA ENTERAL NUTRITION MARKET, BY COUNTRY, 2018–2027 (TONS)
TABLE 185.BRAZIL ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 186.BRAZIL ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 187.BRAZIL ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 188.BRAZIL ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 189.BRAZIL ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 190.BRAZIL ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 191.BRAZIL ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 192.BRAZIL ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 193.SAUDI ARABIA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 194.SAUDI ARABIA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 195.SAUDI ARABIA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 196.SAUDI ARABIA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 197.SAUDI ARABIA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 198.SAUDI ARABIA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 199.SAUDI ARABIA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 200.SAUDI ARABIA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 201.SOUTH AFRICA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 202.SOUTH AFRICA ENTERAL NUTRITION MARKET,